1832 Asset Management L.P. 13F: Cuts ALAB Stake by $245M
1832 Asset Management L.P. trimmed its holdings in Astera Labs, Inc. by 36.8%, according to its latest 13F filing.
Reviewed by automated data checks against the source filing. How we make and check alerts
1832 Asset Management L.P. sold 496,300 shares from its stake in Astera Labs, Inc. ($ALAB), a 36.84% decrease, according to a 13F filing with the SEC dated May 14, 2026. It reported 850,700 shares worth $420.59 million at the end of the quarter.
Since the filing, $ALAB is up 30.3% after 1 week, up 70.2% after 1 month and up 25.0% to date (from the $228.64 close on May 14, 2026).
Find the original: 1832 Asset Management L.P. 13F filings on SEC EDGAR
ALAB
Astera Labs, Inc.
Key Points
- 1832 Asset Management L.P. cut its position in Astera Labs, Inc. by 496,300 shares, reducing its total stake to 850,700 shares valued at about $420.6 million.
- Astera Labs shares traded at $494.4 on May 14, 2026, close to its recent peak of $499.48, reflecting strong interest in semiconductor technologies.
- Analysts maintain a positive outlook on Astera Labs with a consensus 'buy' rating and a target mean price of $391.77.
Get $ALAB trade alerts by text
We text you when insiders, Congress or big funds trade $ALAB. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Astera Labs, Inc. alert may contain errors. Disclosures
1832 Asset Management Cuts Position
1832 Asset Management L.P. reduced its stake in Astera Labs, Inc. (ALAB) by 496,300 shares, a 36.8% decrease, according to its latest Form 13F filing. The fund now holds 850,700 shares valued at approximately $420.6 million as of May 14, 2026.
1832 Asset Management L.P. vs. the S&P 500
Hypothetical returns from 1832 Asset Management L.P.'s disclosed trades, not real profit or advice. How we model this.
Institutional Activity in Astera Labs
While 1832 Asset Management has cut its position, other institutional investors have been active. Notably, PNC Financial Services increased its stake in Astera Labs by over 15%, and UBS Asset Management raised its holdings by 12.7%. These moves come amid a backdrop of mixed trading activity among other funds, with some reducing their stakes significantly.
Stock Performance and Market Context
Astera Labs shares were trading at $494.4 on May 14, 2026, just shy of its 52-week high of $499.48. This price point suggests strong market interest in the semiconductor sector, particularly given the company's focus on cloud and AI connectivity solutions. The stock has seen notable volatility, with a 52-week low of $97.89, showcasing its dramatic ascent.
Recent Earnings
Astera Labs reported revenue of approximately $1.2 billion for the last fiscal year, reflecting a growth rate of about 1.045%. The company's net margin stands at 30.7%, indicating efficient operations. The next earnings report is scheduled for November 3, 2026, which could provide further insight into its financial health.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.
-
Profit surprise
EBITDA missed by 34 percent. Operating income missed by 40 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
10 target raises.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 13.0 points.
Earnings Call Summary
Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.
Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Astera Labs, Inc.
On June 24, 2026, Bethany Mayer sold 686 shares of Astera Labs at an average price of $395.04, totaling about $271,000. This transaction was part of a planned sale, reflecting the insider's strategy rather than a reaction to the company's performance.
Analysts Set New Price Targets
On August 17, 2026, Northland Capital Markets upgraded Astera Labs to an 'Outperform' rating with a target price of $350. TD Cowen and Morgan Stanley maintained their ratings, with targets of $375 and $382, respectively. The consensus among analysts remains positive, with 22 opinions and a mean price target of $391.77.
What Astera Labs, Inc. Does
Astera Labs, Inc. designs and sells semiconductor products aimed at enhancing connectivity for cloud and AI infrastructure. Its innovative solutions are critical for hyperscalers and original equipment manufacturers, making it a key player in the technology sector.
What's Ahead for Astera Labs, Inc.
Investors will be watching for Astera Labs' upcoming earnings report on November 3, 2026, as well as further institutional filings that may affect its stock performance. The recent 13F filings provide a backward-looking view of institutional holdings, and further changes could indicate evolving investor sentiment.
Related Filing Alerts
Source: 1832 Asset Management L.P.'s 13F filing on $ALAB (May 14, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: 1832 Asset Management L.P. 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts